Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 7.4B | 7.5B | 7.0B | 7.2B |
Cost of revenue | 4.1B | 4.2B | 4.0B | 4.2B |
Gross profit | 3.2B | 3.3B | 3.0B | 3.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 1.1B | 1.2B | 1.2B | 1.1B |
Other operating expenses | — | — | — | — |
Operating income | 2.1B | 2.2B | 1.8B | 1.9B |
Non operating interest income | ||||
Income | 297M | 315M | 299M | 304M |
Expense | 25M | -29M | 97M | 26M |
Other income expense | 2.5B | -14M | 101M | 86M |
Pretax income | 4.8B | 2.5B | 2.1B | 2.2B |
Tax provision | 446M | 423M | 367M | 432M |
Net income | 4.4B | 2.1B | 1.7B | 1.8B |
Basic EPS | 2.8 | 1.3 | 1.0 | 1.1 |
Diluted EPS | 2.8 | 1.3 | 1 | 1.1 |
Basic average shares | 1.5B | 1.5B | 1.5B | 1.5B |
Diluted average shares | 1.5B | 1.6B | 1.6B | 1.6B |
EBITDA | 4.9B | 2.5B | 2.2B | 2.3B |
Net income from continuing op. | — | — | — | — |
Minority interests | -97M | -119M | -126M | -112M |
Preferred stock dividends | — | — | — | — |